Reduced Vancomycin Susceptibility in Clostridioides difficile is Associated with Lower Rates of Initial Cure and Sustained Clinical Response.
Taryn A EubankChetna DurejaKevin W GareyJulian G HurdleAnne J Gonzales-LunaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Reduced vancomycin susceptibility in C. difficile was associated with decreased odds of 30-day SCR and lower 14-day initial cure rates in the studied patient cohort.